The bitter truth
In Bottle of Lies: Ranbaxy and The Dark Side of Indian Pharma, author Katherine Eban investigates the fall of Ranbaxy — a doom of its own making
September 27, 2019
Early Mover
What makes Intas the most valuable privately-held pharma company in India
Krishna Gopalan - June 09, 2017
Here For Good
Despite the excise tax exemptions ending in a couple of years, Baddi is still seen as a hospitable cluster
Himanshu Kakkar - February 07, 2017
Vivek Pandey
Private portfolio manager Vivek Pandey is backing Wockhardt thanks to its long ANDA pipeline
Vivek Pandey - December 10, 2015
On safer shores
Bharuch is booming on the back of great roads, ports and a powered-up electrical grid
Krishna Gopalan - July 02, 2015
